BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 187790)

  • 1. Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat.
    Cockerell GL; Hoover EA; Krakowka S; Olsen RG; Yohn DS
    J Natl Cancer Inst; 1976 Nov; 57(5):1095-9. PubMed ID: 187790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of normal lymphocyte mitogenic reactivity by serum from feline leukemia virus-infected cats.
    Cockerell GL; Hoover EA
    Cancer Res; 1977 Nov; 37(11):3985-9. PubMed ID: 198125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte mitogen reactivity in feline leukemia virus-infected cats and identification of feline T and B lymphocytes.
    Cockerell GL; Krakowka S; Hoover EA; Olsen RG; Yohn DS
    Bibl Haematol; 1975 Oct; (43):81-3. PubMed ID: 183735
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of feline T-and B-lymphocytes and identification of an experimentally induced T-cell neoplasm in the cat.
    Cockerell GL; Krakowka S; Hoover EA; Olsen RG; Yohn DS
    J Natl Cancer Inst; 1976 Oct; 57(4):907-13. PubMed ID: 187781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.
    Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG
    Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective impairment of humoral immunity in feline leukemia virus-induced immunodeficiency.
    Pardi D; Hoover EA; Quackenbush SL; Mullins JI; Callahan GN
    Vet Immunol Immunopathol; 1991 Jul; 28(3-4):183-200. PubMed ID: 1659028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
    Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
    Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the short-lived suppressive function of peripheral leukocytes in feline retrovirus-infected cats.
    Stiff MI; Olsen RG
    J Clin Lab Immunol; 1982 Feb; 7(2):133-8. PubMed ID: 6279852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunologic aspects of FeLV-induced immunosuppression.
    Ogilvie GK; Tompkins MB; Tompkins WA
    Vet Microbiol; 1988 Jul; 17(3):287-96. PubMed ID: 2847393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.
    Jackson ML; Wood SL; Misra V; Haines DM
    Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and mitogenesis of feline lymphocyte populations.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    Int Arch Allergy Appl Immunol; 1982; 68(3):226-32. PubMed ID: 7044986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats.
    Levy LS; Fish RE; Baskin GB
    J Virol; 1988 Dec; 62(12):4770-3. PubMed ID: 2846887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia associated with feline leukemia virus infection in cats.
    Mackey L; Jarrett W; Jarrett O; Laird H
    J Natl Cancer Inst; 1975 Jan; 54(1):209-17. PubMed ID: 163317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines.
    Dunlap JE; Nichols WS; Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1979 Mar; 39(3):956-8. PubMed ID: 218726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of feline leukemia virus-induced leukemogenesis in cats exposed to methylnitrosourea.
    Schaller JP; Mathes LE; Hoover EA; Olsen RG
    Int J Cancer; 1979 Nov; 24(5):700-5. PubMed ID: 93586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic feline leukemia virus infection alters arachidonic acid proportions in vivo and in vitro.
    Williams LL; Lewis MG; Olsen RG; Lafrado LJ; Horrocks LA; Rojko JL
    Proc Soc Exp Biol Med; 1993 Feb; 202(2):239-45. PubMed ID: 8380929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline leukemia virus infection: age-related variation in response of cats to experimental infection.
    Hoover EA; Olsen RG; Hardy WD; Schaller JP; Mathes LE
    J Natl Cancer Inst; 1976 Aug; 57(2):365-9. PubMed ID: 187771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B and T cells in a cat with thymic lymphosarcoma.
    Mackey L; Jarrett W; Jarrett O; Wilson L
    J Natl Cancer Inst; 1975 Jun; 54(6):1483-7. PubMed ID: 1079541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of feline leukemia virus infection by adoptive transfer of lectin/interleukin-2-activated lymphocytes, interferon-alpha, and zidovudine.
    Zeidner NS; Mathiason-DuBard CK; Hoover EA
    J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):22-32. PubMed ID: 8399067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.